Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
-
Field
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/ ) and the department has close
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will consider applications to work on a part-time, flexible, and job share basis wherever possible
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/) and the department has close
-
posts On-site nursery On-site gym Enhanced maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl
-
maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will
-
insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more As London’s Global University, we know diversity fosters creativity and innovation, and we want our community
-
at the University of Southampton: https://software-oasis.com/ Our group is developing an innovative class of 3D climate models to explore the atmospheres and climates of Earth and other planets across the Solar
-
University London was established in 1966 and is a leading multidisciplinary research-intensive technology university delivering economic, social and cultural benefits. For more information please visit: https
-
. The UCL GOS ICH, together with its clinical partner Great Ormond Street Hospital for Children, forms the largest concentration of children’s health research outside North America. The 2024-29 GOS ICH